[Treatment of patients at high cardiovascular risk: confirmation and surprising results of the ONTARGET-Study]

Praxis (Bern 1994). 2008 May 14;97(10):559-62. doi: 10.1024/1661-8157.97.10.559.
[Article in German]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Benzoates / therapeutic use*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Ramipril / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Telmisartan

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Ramipril
  • Telmisartan